A61K 31/67
Having sulfur as a ring hetero atom
Official title: having sulfur as a ring hetero atom
A61K31/67 (Having sulfur as a ring hetero atom) appears on 45 US grants and 59 published applications in this corpus.
Search patents in A61K- Granted patents
- 45
- Published applications
- 59
- Assignees
- 49
- Inventors
- 196
- Latest grant
- 16 Jan 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 1 | 0 |
| 1995 | 1 | 0 |
| 1996 | 0 | 0 |
| 1997 | 1 | 0 |
| 1998 | 1 | 0 |
| 1999 | 1 | 0 |
| 2000 | 5 | 0 |
| 2001 | 3 | 0 |
| 2002 | 3 | 2 |
| 2003 | 2 | 3 |
| 2004 | 0 | 0 |
| 2005 | 0 | 1 |
| 2006 | 0 | 3 |
| 2007 | 1 | 1 |
| 2008 | 1 | 1 |
| 2009 | 1 | 1 |
| 2010 | 0 | 4 |
| 2011 | 0 | 2 |
| 2012 | 0 | 2 |
| 2013 | 1 | 1 |
| 2014 | 4 | 2 |
| 2015 | 1 | 5 |
| 2016 | 1 | 2 |
| 2017 | 3 | 4 |
| 2018 | 7 | 4 |
| 2019 | 1 | 1 |
| 2020 | 0 | 2 |
| 2021 | 0 | 4 |
| 2022 | 2 | 4 |
| 2023 | 1 | 0 |
| 2024 | 2 | 2 |
| 2025 | 0 | 6 |
| 2026 | 0 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Method of treating a methionine-dependent cancer16 Jan 2024US 11,872,230 B2Agency for Science, Technology and Research
- Gold(III) complex, a conjugate of the gold(III) complex, a pharmaceutical composition comprising the gold(III) complex and uses and a process for preparing the gold(III) complex9 Jan 2024US 11,866,455 B2
- Method and compositions for protecting tissue26 Dec 2023US 11,850,313 B2London Health Sciences Centre Research Inc.
- Pharmaceutical combinations comprising insulin and at least an agent selected from meloxicam, bromfenac sodium, acetylsalicylic acid, salicyclic acid and paracetamol29 Nov 2022US 11,510,967 B2Eli Lilly and Company
- Method of treating a methionine-dependent cancer5 Jul 2022US 11,376,256 B2Agency for Science, Technology and Research
- Modulator for promoting binding of butyrophilin 3a1/2a123 Jul 2026US 2026/0207637 A1Unicet Biotech Co. LLC.
- Stat6 degraders and uses thereof2 Apr 2026US 2026/0092078 A1Kymera Therapeutics, Inc.
- Sting agonist compounds27 Nov 2025US 2025/0361253 A1
- Phosphorus compound and use thereof2 Oct 2025US 2025/0304608 A1Shanghai Shijiang Biotechnology Co., Ltd
- Mitochondriotropic heteroaryl benzamide potassium channel kv1.3 inhibitors18 Sep 2025US 2025/0289837 A1Max-Planck-Gesellschaft Zur FöRderung Der Wissenschaften E. V.
Most cited
By later US patents
- Method for producing a microparticle46US 6,022,564 ATakeda Chemical Industries, Ltd. · 2000
- Methods of cancer treatment using naaladase inhibitors44US 5,804,602 AGuilford Pharmaceuticals Inc. · 1998
- Phosphinic alkanoic acid derivatives44US 6,071,965 AGuilford Pharmaceuticals Inc. · 2000
- Cancer chemotherapy with 2-deoxy-D-glucose37US 6,670,330 B12003
- IL-8 receptor ligands-drugs for inflammatory and autoimmune diseases34US 6,515,001 B2Chemokine Therapeutic Corporation · 2003